Best Researcher Award
Young-Suk Jung
Pusan National University College of Pharmacy
| Young-Suk Jung |
| Affiliation |
Pusan National University College of Pharmacy |
| Country |
South Korea |
| Scopus ID |
56428348300 |
| Documents |
196 |
| Citations |
5103 |
| h-index |
39 |
| Subject Area |
Biotechnology |
| Event |
Computer Scientists Awards |
| ORCID |
0000-0003-0299-4451 |
Young-Suk Jung is a researcher affiliated with the Pusan National University College of Pharmacy, South Korea. His scholarly work has contributed to biotechnology, pharmaceutical sciences, molecular biology, toxicology, and translational biomedical research. Through a substantial publication record, extensive citation impact, and sustained academic productivity, Jung has established a recognized presence within the international scientific community. His research activities encompass experimental and applied biotechnology, emphasizing cellular mechanisms, disease biology, pharmacological interventions, and innovative therapeutic approaches.[1]
Abstract
This article presents an academic overview of Young-Suk Jung and evaluates his scholarly profile in relation to recognition through the Best Researcher Award. The assessment considers research productivity, publication output, citation influence, interdisciplinary engagement, and scientific contributions within biotechnology and pharmaceutical sciences. Available bibliometric indicators demonstrate substantial research visibility and sustained academic influence, supporting consideration for international research distinction.[1]
Keywords
Biotechnology, Pharmaceutical Sciences, Drug Discovery, Molecular Biology, Toxicology, Biomedical Research, Translational Medicine, Research Excellence, Scientific Impact, Citation Analysis, Academic Recognition, Therapeutic Innovation.
Introduction
Contemporary biotechnology increasingly relies on interdisciplinary research integrating molecular biology, pharmacology, toxicology, and clinical translation. Researchers capable of bridging fundamental biological discoveries with practical therapeutic applications contribute significantly to scientific advancement. Young-Suk Jung’s academic portfolio reflects engagement across these domains through extensive peer-reviewed scholarship and collaborative research initiatives.[1]
The evaluation of academic excellence frequently incorporates publication productivity, citation performance, innovation, and contributions to knowledge generation. Within these criteria, Jung’s research profile demonstrates characteristics associated with internationally recognized scientific achievement.[2]
Research Profile
- 196 indexed scholarly documents.
- More than 5,100 citations across scientific literature.
- h-index of 39 indicating consistent scholarly influence.
- Participation in multidisciplinary biomedical investigations.
The research profile reflects both productivity and impact. Bibliometric indicators suggest that Jung’s publications have received sustained attention from researchers working in biotechnology, pharmacology, toxicology, and related biomedical disciplines.[1]
Research Contributions
Young-Suk Jung has contributed to advancing scientific understanding of disease mechanisms, therapeutic targets, pharmacological responses, and cellular signaling pathways. His work frequently addresses biological processes relevant to human health and disease management.[2]
Publications
Young-Suk Jung has authored and co-authored numerous peer-reviewed publications in biotechnology, pharmaceutical sciences, and biomedical research. The breadth of publication activity demonstrates continuous scholarly engagement and international research collaboration.[1]
Research Impact
Research impact is commonly assessed through citation metrics, publication influence, and knowledge dissemination. With 5,103 citations and an h-index of 39, Young-Suk Jung demonstrates measurable scholarly impact across multiple scientific communities.[1]
The citation performance indicates that his research findings have informed subsequent investigations and contributed to the broader scientific discourse. Such influence is often regarded as an indicator of research quality, relevance, and sustainability within a field.[2]
Award Suitability
Evaluation for the Best Researcher Award generally considers originality, productivity, impact, and contributions to scientific advancement. Based on available bibliometric information, Young-Suk Jung exhibits several attributes commonly associated with award recognition, including sustained publication activity, significant citation influence, interdisciplinary research engagement, and measurable scholarly visibility.[1]
Conclusion
Young-Suk Jung represents an established researcher whose academic profile reflects sustained productivity, measurable scientific influence, and active contributions to biotechnology and pharmaceutical sciences. Available indicators support recognition of his research achievements and demonstrate characteristics consistent with consideration for the Best Researcher Award within an international academic context.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Young-Suk Jung, Author ID 56428348300. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56428348300
- ORCID. (n.d.). Young-Suk Jung researcher profile and scholarly activities.
https://orcid.org/0000-0003-0299-4451
- Jung, Y.-S. et al. (2014). Biomedical and pharmacological research publication.
DOI: https://doi.org/10.1016/j.bcp.2014.09.008
- Computer Scientists Awards. (n.d.). Best Researcher Award information.
https://computerscientists.net/